Biotech’s Lost Archive | IFP
ifp.org · 3,517 words · saved by 2 readers
How to fuel AI by unlocking the FDA’s knowledge of biotech failures
Download PDF Content Summary Motivation The US can’t afford to lose the biotech race Innovation is increasingly driven by start-ups — but regulation favors large incumbents The FDA sits on a treasure trove of data AI could unlock the value — if we unlock the data This is an opportunity for policy and philanthropy Solution Further resources Appendix Additional context on CTDs The current state of obtaining information under FOIA and the legal landscape How bankruptcy law enables the transfer of intellectual assets This essay is part of The Launch Sequence , a collection of concrete, ambit
saved by
related reading
- Biotech’s Lost Archive | IFPifp.org
- Drug Discovery Has No Magic Wandsa16z.news
- Rebuild Biotech for the AI Era | Benchlingbenchling.com
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Systemic Bottlenecks & Misalignmentscurecancer.ai
- Intelligence is not the main bottleneck - by Ruxandra Teslowritingruxandrabio.com
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- AI Versus Eroom's Lawsubstack.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Convictionconviction.com
- What will it take for AI to change drug discovery?writingruxandrabio.com
- Curious cases of financial engineering in biotechowlposting.com